Table 2. Normal rats.
Tail amputation | Bleeding time | Amount of bleeding | PLT before | PLT after | HCT before | HCT after | PT | APTT | TT | FIB |
---|---|---|---|---|---|---|---|---|---|---|
min | mL | x109/L | x109/L | L/L | L/L | ratio (PR) | ratio | sec | g/L | |
Control | 18±3 | 1.92±1.1 | 853±173 | 605±35 | 0.446±0.03 | 0.430±0.04 | 1.30±0.22 | 0.45± 0.16 | 34± 12 | 1.6± 0.22 |
BPC ug | 7±2* | 0.21±0.06* | 820±167 | 685± 22* | 0.461±0.03 | 0.453±0.03 | 1.32±0.25 | 0.41± 0.17 | 40± 11 | 1.8± 0.17 |
BPC ng | 8±2* | 0.24±0.04* | 831±178 | 675± 17* | 0.454±0.04 | 0.446±0.03 | 1.35±0.21 | 0.42± 0.11 | 41± 13 | 1.7± 0.19 |
L-arginine | 29±4* | 1.63±1.2 | 781±123 | 702± 30* | 0.497±0.03 | 0.476±0.03 | 1.29±0.21 | 0.64± 0.18 | 35± 9 | 1.8± 0.23 |
L-NAME | 7±2* | 0.75±0.15* | 677± 105* | 601±40 | 0.481±0.04 | 0.454±0.03 | 1.28±0.19 | 0.66± 0.21 | 30± 8 | 1.8± 0.18 |
L-NAME+ L-arginine | 21±3 | 0.8±0.24* | 695±94* | 442± 15* | 0.482±0.05 | 0.468±0.03 | 1.24±0.22 | 0.51± 0.13 | 46± 14 | 1.8± 0.21 |
L-arginine+BPC 157 ug | 9±2* | 0.57±0.11* | 801±189 | 694± 39* | 0.506±0.04 | 0.490±0.04 | 1.28±0.21 | 0.49± 0.17 | 39± 11 | 1.8± 0.27 |
L-NAME+ BPC 157 ug | 8±2* | 0.40±0.12* | 758±122 | 654± 25* | 0.472±0.03 | 0.465±0.04 | 1.30±0.22 | 0.49± 0.18 | 40± 10 | 1.8± 0.19 |
L-NAME+L-arginine+ BPC 157 ug | 10±3* | 0.30±0.09* | 788±133 | 655± 31* | 0.479±0.03 | 0.466±0.03 | 1.34±0.23 | 0.5± 0.13 | 48± 13 | 1.8± 0.18 |
Tail amputation, bleeding time, amount of bleeding, PLT, HCT, PT, APTT, TT, FIB, values in normal rats (10 rats at least per group) with amputation challenged with BPC 157 (10 μg/kg, 10 ng/kg), L-NAME (5 mg/kg), L-arginine (100 mg/kg) given alone and/or together,applied intraperitoneally, at 30 minutes before amputation while controls received simultaneously an equivolume of saline (5ml/kg intraperitoneally). Mean ± SD,
*P<0.05 at least vs. control.